Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pseudomonas Aeruginosa Injection Combined With Polyvinylpyrrolidone-Iodine in Immediate Breast Reconstruction Surgery
NCT07460297Enrolling by invitation
- Sponsor
- Jianyi Li
- Start
- Apr 2025
- Primary completion
- Jan 2028
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Randomised trial of pseudomonas aeruginosa injection in Seroma, surgical site infection (SSI) and capsular contracture (2 arms), sponsored by Jianyi Li. Primary endpoints: Seroma Rate at 30 days, Drainage Tube Removal Time at 30 days and 1 more. Started Apr 2025; status: enrolling by invitation.
02
Drugs
pseudomonas aeruginosa injection
03
Conditions
Seromasurgical site infection (SSI)capsular contracture
Beyond the preview
Go deeper on NCT07460297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07460297.